The DES Center

Filter Your Results

 

News

 

ABSORB IV Results Show Need for Improvements in BVS Technology and Technique

October 31, 2017 -- Thirty-day results from ABSORB IV randomized everolimus-eluting trial of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) found the BVS to…

Cordis Unveils Comprehensive Interventional Cardiology Portfolio With Coronary Stents

October 30, 2017­ -- Cordis, a Cardinal Health Company announced the addition of two new coronary stents to its comprehensive interventional cardiology portfolio, the Tryt…

Three-Year ABSORB III Trial Data Presented and Published for Abbott Vascular's BVS

October 31, 2017 -- The ABSORB III study assessed clinical outcomes through 3 years after implantation of the Absorb everolimus-eluting poly-L-lactic acid -- based bioresorbab…

CE Mark Approval for Abbott Vascular's Xience Sierra

October 30, 2017 -- Abbott Vascular announced it has received European CE Mark approval for Xience Sierra, the newest generation of the company’s Xience everolimus-eluti…

FDA Approves Expansion of CeloNova's COBRA REDUCE Trial

October 26, 2017 -- CeloNova BioSciences, Inc. announced that the US Food and Drug Administration (FDA) approved expansion of the company's ongoing clinical trial of its C…

DEB Shows Noninferiority to DES in Patients With In-Stent Restenosis

October 30, 2017 -- The DARE multicenter randomized clinical trial was presented at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium be…

One-Year Results Presented From the Pivotal HARMONEE Trial of OrbusNeich's Combo Dual-Therapy Stent

October 30, 2017 -- OrbusNeich announced that results from the HARMONEE registration trial -- the Japan-United States harmonized assessment by randomized multicenter study -- …

Medinol's EluNIR DES Receives CE Mark Approval

October 26, 2017 -- Medinol USA announced that it has obtained European CE Mark approval for its EluNIR ridaforolimus-eluting coronary stent system, which features a low metal…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.